Abstract
Hemangiosarcoma (HSA) is a fatal cancer in both humans and dogs. In humans, HSA behaves and has lesions with similar distributions to canine HSA. In both species, metastases are commonly seen and adjuvant chemotherapy provides only a modest benefit. There are many important mutated tumor supressor genes related to the pathogenesis of human, canine, and murine HSA. Identification of new tu…